A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus
Clinical trial NCT01405885 · COMPLETED
Trial details
- NCT number
- NCT01405885
- Sponsor
- Inovio Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2013-08-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.